Skip to NavigationSkip to content

Pharmafile - Manufacturing and Production News

Researchers at Imperial College London (ICL) and Johannes Gutenberg University Mainz have shown that xenon prevents early death and long-term...
MSD has made it known that its cancer immunotherapy Keytruda (pembrolizumab) failed to meet its primary endpoint in a Phase 3 study evaluating its...
An artificial intelligence (AI) is better than specialist doctors at diagnosing lung cancer, according to a study from researchers at Google and...
Gilead, Janssen and BMS accused of forging anticompetitive deal; Novartis buy Takeda's dry eye drug Xiidra for $5.3 billion; NHS England to pay for...
Healthcare conglomerate Johnson & Johnson has said it will be investing €100 million into the expansion of its Vision Care manufacturing...
A study led by researchers at the University of Oxford has argued that the administration of preventative antibiotics to all mothers following...
The FDA has expanded the indication for Regeneron’s Eylea (aflibercept) to include all stages of diabetic retinopathy.
Spending on mental health varies dramatically between regions in England, according to analysis from mental health charity Mind.
MSD has revealed that Keytruda (pembrolizumab) will be made available to NHS Scotland patients after the Scottish Medicines Consortium (SMC)...
The Office of the United States Trade Representative (USTR) has said pharmaceuticals will not be subject to potential US tariffs on Chinese imports.
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches